Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

133
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
133
Vaccinations01:51

Vaccinations

44.1K
Overview
44.1K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

170
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
170
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

211
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
211
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

220
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
220

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Undernutrition and tuberculosis: time to recalibrate the global response.

The Lancet. Global health·2026
Same author

Blueprint for scalable laboratory driven quality management systems: Insights from tuberculosis diagnostic pilots in India.

The Indian journal of tuberculosis·2025
Same author

Characteristics of children and adolescents with multidrug-resistant and rifampicin-resistant tuberculosis and their association with treatment outcomes: a systematic review and individual participant data meta-analysis.

The Lancet. Child & adolescent health·2025
Same author

My tuberculosis epidemiology journey: Implications for TB program interventions, activities and strategy.

The Indian journal of tuberculosis·2024
Same author

Assessing the impact of COVID-19 management on the workload of human resources working in India's National Tuberculosis Elimination Program.

BMC health services research·2024
Same author

Facilitators and Barriers for Private Health Sector Engagement for TB Care in India: A Systematic Review and Meta-Synthesis of Qualitative Research.

Global health, science and practice·2024
Same journal

Interpreting maternal and neonatal outcomes in COVID-19-affected pregnancies.

The Indian journal of medical research·2026
Same journal

Incorporating patient- and caregiver-derived needs into national cancer research priority setting in India.

The Indian journal of medical research·2026
Same journal

Advances in glioblastoma: Is there light at the end of the tunnel?

The Indian journal of medical research·2026
Same journal

Authors' response.

The Indian journal of medical research·2026
Same journal

Formulation and sensory evaluation of nutrient-dense complementary food mixes for infants and young children aligned with national nutritional standards in India: A D-optimal mixture design approach.

The Indian journal of medical research·2026
Same journal

Prevalence of hypothyroidism among pregnant women and associated feto-maternal outcomes in India: Systematic review and meta-analysis.

The Indian journal of medical research·2026
查看所有相关文章

相关实验视频

Updated: Jun 5, 2025

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

2.1K

结核病疫苗:当前情况和挑战

Kuldeep Singh Sachdeva1, Vineet K Chadha2

  • 1Molbio Diagnostics, Verna, Goa, India.

The Indian journal of medical research
|December 5, 2024
PubMed
概括
此摘要是机器生成的。

开发新的结核病 (TB) 疫苗对全球健康至关重要. 目前的工作重点是改进现有疫苗,探索新的方法,在所有人群中有效打击结核病.

关键词:
成人疫苗接种成年人疫苗接种在BCG中,BCG是BCG.挑战 挑战 挑战 挑战 挑战新的方法采用了新的方法.更多的疫苗都是新的.管道管道管道管道管道管道结核病是一种肺结核病.

更多相关视频

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

896
Expression of Exogenous Antigens in the Mycobacterium bovis BCG Vaccine via Non-genetic Surface Decoration with the Avidin-biotin System
10:11

Expression of Exogenous Antigens in the Mycobacterium bovis BCG Vaccine via Non-genetic Surface Decoration with the Avidin-biotin System

Published on: January 31, 2018

9.3K

相关实验视频

Last Updated: Jun 5, 2025

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

2.1K
Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

896
Expression of Exogenous Antigens in the Mycobacterium bovis BCG Vaccine via Non-genetic Surface Decoration with the Avidin-biotin System
10:11

Expression of Exogenous Antigens in the Mycobacterium bovis BCG Vaccine via Non-genetic Surface Decoration with the Avidin-biotin System

Published on: January 31, 2018

9.3K

科学领域:

  • 疫苗学 疫苗学 疫苗学
  • 传染性疾病 传染性疾病
  • 公共卫生 公共卫生

背景情况:

  • 结核病 (TB) 仍然是一个重大的全球卫生挑战,导致广泛的发病率和死亡率.
  • 目前的Bacillus Calmette-Guérin (BCG) 疫苗在不同的人口和年龄组的有效性有局限性.
  • 为了消除结核病,需要开发一种更有效的疫苗.

研究的目的:

  • 审查结核病疫苗开发的最新进展.
  • 讨论新的结核病疫苗的新战略和当前的管道.
  • 突出结核病疫苗学的持续挑战和未来方向.

主要方法:

  • 关于结核病疫苗的最新科学文献和临床试验数据的审查.
  • 对新型疫苗方法的分析,包括亚单元,病毒载体和基于DNA的疫苗.
  • 检查BCG疫苗重新定位和助推剂开发的策略.

主要成果:

  • 在开发新型结核病候选疫苗方面取得了重大进展.
  • 一些有前途的候选疫苗正在临床试验的各个阶段.
  • 在实现对结核病的广泛和持久保护方面,仍然存在挑战.

结论:

  • 在所有人群中具有高效的新型结核病疫苗对于结核病根除至关重要.
  • 在疫苗开发方面,持续的研究和创新至关重要.
  • 应对尚未解决的挑战将为未来的结核病疫苗成功铺平道路.